balofloxacin has been researched along with carbostyril in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T; Nishino, T; Otsuki, M | 1 |
| Kojima, K; Matsubara, S; Matsumoto, M; Nagano, H; Yokota, T | 1 |
| Abe, T; Miyao, M; Motoyama, M; Nakagawa, T; Okutomi, T; Ooishi, M; Sasagawa, T | 1 |
| Ito, T; Matsumoto, M; Nishino, T | 1 |
| Fukuyama, M; Imagawa, Y; Kawakami, K; Suda, O | 1 |
| Fukuda, H; Irimajiri, S; Masuda, G; Nitta, Y; Obana, M; Sakamoto, Y; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T | 1 |
| Hiramatsu, Y; Ishigai, M; Ishitani, Y; Kinoshita, H; Nakagawa, T; Ohkubo, K; Okazaki, A | 1 |
| Hayakawa, N; Ishigai, M; Kato, M; Kinoshita, H; Nakagawa, T; Ohkubo, K; Okazaki, A; Okutomi, T | 1 |
| Ito, T; Koizumi, K; Kojima, K; Nagano, H; Nishino, T | 1 |
| Mizuno, A; Nakashima, M; Ohsawa, Y; Uematsu, T | 1 |
| Akashi, A; Arai, S; Furudera, T; Gohara, Y; Kuwano, K; Matsubara, S; Matumoto, M; Tseng, CC | 1 |
| Hasegawa, T; Kamide, R; Marutani, K; Matsubara, S; Matsumoto, M; Miyoshi, A; Nagamuta, M; Nagano, H; Otabe, Y; Tanaka, K | 1 |
| Hashimoto, N; Ngoma, M; Takashima, I | 1 |
| Andoh, S; Horiba, M; Ishikawa, K; Katoh, S; Naide, Y; Suzuki, K; Yanaoka, M | 1 |
| Cho, N; Kimura, T; Kunii, K; Miyakawa, Z; Notake, Y; Shimizu, A | 1 |
| Asano, T; Haruta, K; Kasuga, Y; Kurata, M; Nakamura, H; Nanba, E | 1 |
| Chilima, BZ; Okazawa, Y; Tanno, K; Tosaka, M; Yamane, N | 1 |
| Kanamaru, M; Kozawa, O; Matsuno, H; Nagashima, S; Niwa, M; Uematsu, T | 1 |
| Chen, D; Prahalad, AK; Rosen, JE; Schluter, G; Spratt, TE; Williams, GM | 1 |
| Fujimura, S; Kikuchi, T; Lutfor, AB; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
5 trial(s) available for balofloxacin and carbostyril
| Article | Year |
|---|---|
[clinical study of balofloxacin on infectious enteritis and assessment of the fecal drug concentration and intestinal microbial flora in patients with inpatients with infectious enteritis. Research group of balofloxacin on infectious enteritis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Drug Administration Schedule; Dysentery, Bacillary; Enteritis; Escherichia coli; Escherichia coli Infections; Feces; Female; Fluoroquinolones; Humans; Intestines; Male; Middle Aged; Quinolones; Salmonella; Shigella | 1995 |
Analysis of a new fluoroquinolone derivative (Q-35) in human scalp hair as an index of drug exposure and as a time marker in hair.
Topics: Adult; Anti-Infective Agents; Environmental Exposure; Fluoroquinolones; Hair; Humans; Male; Middle Aged; Quinolones; Reference Values; Time Factors; Tissue Distribution | 1994 |
Laboratory and clinical study of balofloxacin (Q-35), a new fluoroquinolone, in urinary tract infection.
Topics: Anti-Infective Agents; Diffusion; Enterococcus faecalis; Female; Fluoroquinolones; Humans; Male; Prostate; Quinolones; Serum Bactericidal Test; Urinary Tract Infections | 1995 |
Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
Topics: Adult; Anti-Infective Agents; Bacteria; Female; Fluoroquinolones; Genital Diseases, Female; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Puerperal Infection; Quinolones; Uterus | 1995 |
Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
Topics: Aged; Aging; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Piperazines; Quinolones | 1996 |
15 other study(ies) available for balofloxacin and carbostyril
| Article | Year |
|---|---|
In vitro antibacterial activity of Q-35, a new fluoroquinolone.
Topics: Anti-Infective Agents; Bacteria; DNA, Superhelical; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Staphylococcus aureus; Topoisomerase II Inhibitors | 1992 |
Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation.
Topics: Animals; Anti-Infective Agents; Bacteria; Cell Survival; Drug Stability; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Photochemistry; Quinolones; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured; Ultraviolet Rays | 1992 |
[Pharmacokinetics of balofloxacin in the intraocular tissues of pigmented rabbits].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Aqueous Humor; Eye; Fluoroquinolones; Half-Life; Male; Pigmentation; Quinolones; Rabbits; Tissue Distribution | 1995 |
Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.
Topics: Anti-Infective Agents; Base Sequence; DNA Gyrase; DNA Topoisomerases, Type II; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis | 1995 |
[In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enteritis; Enterobacteriaceae Infections; Escherichia coli; Fluoroquinolones; Humans; Norfloxacin; Ofloxacin; Quinolones; Salmonella; Shigella | 1995 |
Determination of the new fluoroquinolone balofloxacin and its metabolites in biological fluids by high performance liquid chromatography.
Topics: Animals; Anti-Infective Agents; Bile; Chromatography, High Pressure Liquid; Fluoroquinolones; Glucuronates; Humans; Hydrolysis; Quinolones; Rats; Spectrometry, Fluorescence | 1995 |
Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Biological Availability; Biotransformation; Dogs; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Mice; Mice, Inbred Strains; Quinolones; Rats; Rats, Sprague-Dawley | 1995 |
Inhibitory activity on DNA gyrase and intracellular accumulation of quinolones: structure-activity relationship of Q-35 analogs.
Topics: Anti-Infective Agents; Bacteria; Fluoroquinolones; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1994 |
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Cricetinae; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Lung; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1993 |
Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light.
Topics: Absorption; Administration, Oral; Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Dermatitis, Phototoxic; Drug Stability; Ear; Female; Fluoroquinolones; Inflammation; Mice; Mice, Inbred BALB C; Quinolones; Spectrophotometry, Ultraviolet; Tissue Distribution; Ultraviolet Rays; Whole-Body Irradiation | 1993 |
Antimicrobial effects of a new carboxyquinolone drug, Q-35, on five serogroups of Leptospira interrogans.
Topics: Anti-Infective Agents; Fluoroquinolones; Kinetics; Leptospira interrogans; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Quinolones | 1993 |
Flush induced by fluoroquinolones in canine skin.
Topics: Animals; Anti-Infective Agents; Dogs; Female; Fluoroquinolones; Flushing; Histamine Antagonists; Male; Ofloxacin; p-Methoxy-N-methylphenethylamine; Quinolones; Skin | 1995 |
[Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Culture Media; Fluoroquinolones; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Quinolones | 1996 |
A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine after ultraviolet-A irradiation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Aza Compounds; Cell Line; Deoxyguanosine; Epithelium; Fluoroquinolones; Liver; Moxifloxacin; Quinolines; Quinolones; Rats; Ultraviolet Rays | 1997 |
Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
Topics: Anti-Infective Agents; Dioxolanes; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Humans; Piperazines; Point Mutation; Polymerase Chain Reaction; Quinolones; Staphylococcus aureus | 1998 |